Int. VTE & Cancer Guidelines 17+

ITAC VTE & cancer guidelines

Rachid Nouar

Designed for iPad

    • Free

Screenshots

Description

This application is available in English, French, Spanish, Portuguese, and Russian. The language of the app will be determined by the language setting of the user’s smartphone.

Based on international guidelines published in 2022, which were developed with methodological support from the Institut National du Cancer (INCa) in France and endorsed by the International Society on Thrombosis and Hemostasis (ISTH), this app is a practical step-by-step guide for the prophylaxis and treatment of venous thromboembolism (VTE: deep vein thrombosis (DVT), pulmonary embolism (PE), catheter-related thrombosis) in patients with cancer, including:
• Prophylaxis in hospitalized and ambulatory patients
• Recommendations for the treatment of both non-catheter and catheter-related VTE
• Specific recommendations related to special cancer situations
• Recommendations for initial, short-term, and long-term treatment

This treatment algorithm for anticoagulant use (low molecular weight heparins (LMWH), direct oral anticoagulants (DOAC), and vitamin K antagonists (VKA)) is intended for physicians and other healthcare professionals treating patients with cancer. It should not replace clinical judgement. It is based on clinical practice guidelines published in 2022:
Farge D*, Frere C*, Connors JM, Khorana AA, Kakkar A, Ay C, Muñoz A, Brenner B, Prata PH, Brilhante D, Antic D, Casais P, Guillermo Esposito MC, Ikezoe T, Abutalib SA, Meillon-García LA, Bounameaux H, Pabinger I, Douketis J; International Initiative on Thrombosis and Cancer (ITAC) advisory panel. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol. 2022 Jul;23(7):e334-e347.

While these guidelines rely on the best available evidence at the time of publication, the clinician is advised to use clinical judgement when making decisions about prophylaxis and treatment of cancer-associated thrombosis (CAT).

APP AUTHORS / STEERING COMMITTEE
Professor Dominique Farge (France) (Co-Chair)
Professor James Douketis (Canada) (Co-Chair)
Dr Syed Abutalib (United States)
Professor Cihan Ay (Austria)
Dr Darko Antic (Serbia)
Professor Henri Bounameaux (Switzerland)
Professor Benjamin Brenner (Israel)
Dr Dialina Brilhante (Portugal)
Dr Patricis Casais (Argentina)
Dr Jean M. Connors (United States)
Professor Corinne Frere (France)
Professor Maria Cecilia Guillermo Esposito (Uruguay)
Professor Takayuki Ikezoe (Japan)
Professor Alok A. Khorana (United States)
Right Honourable Professor Lord Ajay Kakkar (United Kingdom)
Professor Luis Meillon-Garcia (Mexico)
Professor Andres Munoz-Martin (Spain)
Professor Ingrid Pabinger (Austria)
Dr Pedro Henrique Prata (Brazil)

ABOUT ITAC-CME
The International Initiative on Thrombosis and Cancer (ITAC-CME) is the international section of the Groupe Francophone Thrombose et Cancer (GFTC). A multidisciplinary group, the members of ITAC-CME are clinicians and researchers from across the globe, led by a core group of GFTC members. Through education of physicians, nurses, and allied health professionals, ITAC-CME is committed to disseminating relevant and peer-reviewed prophylaxis and treatment guidelines for VTE in cancer that will help to reduce a substantial economic burden on health care systems and improve the lives of millions of patients worldwide.

What’s New

Version 2.0.1

- Update based on the 2022 ITAC international guidelines
- Various bug fixes

App Privacy

The developer, Rachid Nouar, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.

Data Linked to You

The following data may be collected and linked to your identity:

  • Contact Info
  • Identifiers

Data Not Linked to You

The following data may be collected but it is not linked to your identity:

  • Usage Data
  • Diagnostics

Privacy practices may vary based on, for example, the features you use or your age. Learn More

You Might Also Like

FROG Oncogériatrie
Medical
SFMV 2024
Medical
Riete Registry
Medical
Anticoagulation Manager
Medical
Manuel pratique d’oncologie
Medical
IPSS-M Risk Calculator
Medical